Baird Financial Group
BIVV

Baird Financial Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Baird Financial Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,032
Closed -$811K – 1332
2017
Q4 		$811K Sell
15,032
-5,082
-25% -$278K 0.01% 874
2017
Q3 		$1.15M Sell
20,114
-1,401
-7% -$82.1K 0.01% 758
2017
Q2 		$1.29M Sell
21,515
-32,658
-60% -$1.86M 0.01% 724
2017
Q1 		$2.95M Buy
+54,173
New +$2.67M 0.02% 503

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Baird Financial Group's BIVV Position: Q1 2018 in Review

Baird Financial Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 15,032 shares — an estimated $811K sold.

Baird Financial Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.95M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Baird Financial Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Baird Financial Group sold 15,032 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $811K.
  • Baird Financial Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Baird Financial Group's Bioverativ Inc. Common Stock position peaked at $2.95M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Baird Financial Group's 13F filing for Q1 2018, filed 14 May 2018.